ROTHBLATT MARTINE A

Martine A. Rothblatt is the founder, chairperson and chief executive officer of United Therapeutics, a Silver Spring, Maryland–based biopharmaceutical company focused on therapies for pulmonary hypertension and organ‑preservation and xenotransplantation technologies. Her executive role and company biography are documented in United Therapeutics’ SEC filings and corporate disclosures.^[1]

Career Background

• Founded United Therapeutics in 1996 and has led the company in executive roles since inception.^[1]
• Created or led earlier satellite and communications ventures, including roles tied to SiriusXM and GeoStar, before moving into biotechnology entrepreneurship.^[2]
• Holds advanced degrees in law and business from the University of California, Los Angeles and a Ph.D. in medical ethics; academic background is documented in public biographical profiles.^[2]

Current Positions

• Chairperson and Chief Executive Officer — United Therapeutics Corporation (Nasdaq: UTHR).^[1]
• Founder and Chair of the board — United Therapeutics Corporation; serves in executive leadership and board roles as disclosed in company proxy and SEC materials.^[1]

SEC Filing Context

• Company SEC filings and EDGAR records list Dr. Rothblatt as United Therapeutics’ Chairperson and CEO and show numerous insider Form 3/4/5 submissions associated with her reporting status.^[1]
• Public Form 4 filings for Dr. Rothblatt appear regularly in the SEC database, reflecting frequent insider transactions reported under her name.^[3]